Volume 8, Number 10—October 2002
THEME ISSUE
Bioterrorism-related Anthrax
Bioterrorism-related Anthrax
Surveillance for Anthrax Cases Associated with Contaminated Letters, New Jersey, Delaware, and Pennsylvania, 2001
Christina G. Tan*†
, Hardeep S. Sandhu*, Dana C. Crawford*, Stephen C. Redd*, Michael J. Beach*, James W. Buehler*, Eddy A. Bresnitz†, Robert W. Pinner*, Beth P. Bell*, and the Regional Anthrax Surveillance Team1the Centers for Disease Control and Prevention New Jersey Anthrax Surveillance Team2
, Hardeep S. Sandhu*, Dana C. Crawford*, Stephen C. Redd*, Michael J. Beach*, James W. Buehler*, Eddy A. Bresnitz†, Robert W. Pinner*, Beth P. Bell*, and the Regional Anthrax Surveillance Team1the Centers for Disease Control and Prevention New Jersey Anthrax Surveillance Team2
Figure 1
Figure 1. Counties participating in active surveillance, New Jersey, Pennsylvania, and Delaware, 2001.
1 Regional Anthrax Surveillance Team: Leroy Hathcock, Paula Eggers, Kumar Nalluswami, Esther Chernak, Elyse Farnon, Chad Schaben, and Pat Sassano.
2 Centers for Disease Control and Prevention New Jersey Anthrax Surveillance Team: Chidinma Alozie-Arole, Gregory Armstrong, Shadi Chamany, Donita R. Croft, Colleen Crowe, Mary Dott, Anthony E. Fiore, Dara S. Friedman, Jessica Gardom, Susan Goldstein, Carolyn M. Greene, Beth C. Imhoff, Malinda Kennedy, Michelle McConnell, Peter D. McElroy, Cindi Pecoraro, Lisa Roth-Edwards, and Nicole Tucker.
Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.